Home
|
News
|
Careers
|
Contact Us
About Vanda
Product Pipeline
24
Partnering
Investor Relations
Investor Relations
Presentations
Receive E-mail Alerts
Date
Title
06/06/13
Jefferies Global Healthcare Conference Presentation
05/09/13
Q1 2013 Vanda Pharmaceuticals Inc. Earnings Conference Call
04/05/13
Vanda Pharmaceuticals Inc. at BioCentury Publications Future Leaders in the Biotech Industry Conference
04/04/13
BioCentury Publications Future Leaders in the Biotech Industry Conference Presentation
03/04/13
Cowen and Company 33rd Annual Health Care Conference Presentation
02/12/13
Vanda Pharmaceuticals Q4 2012 Earnings Call Transcript
02/12/13
Q4 2012 Vanda Pharmaceuticals Inc. Earnings Conference Call
01/31/13
Vanda Pharmaceuticals Inc. Conference Call
01/23/13
Vanda Announces Positive Results in the Second Phase III Study (RESET) of Tasimelteon for the Treatment of Non-24-Hour Disorder - Conference Call Transcript
01/23/13
Vanda Announces Positive Results in the Second Phase III Study (RESET) of Tasimelteon for the Treatment of Non-24-Hour Disorder -Conference Call
12/18/12
Vanda Pharmaceuticals Inc. Announces Positive Phase III Results For Tasimelteon In The Treatment Of Non-24-Hour Disorder- Conference Call
11/14/12
Vanda Pharmaceuticals Inc. at Lazard Capital Markets Healthcare Conference
11/14/12
Lazard Capital Markets Healthcare Conference Presentation
11/07/12
Vanda Pharmaceuticals Q3 2012 Earnings Call Transcript
11/07/12
Q3 2012 Vanda Pharmaceuticals Inc. Earnings Conference Call
09/07/12
Vanda Pharmaceuticals Inc. at BioCentury and Thomson Reuters NewsMakers in the Biotech Industry
09/05/12
Stifel Nicolaus Healthcare Conference Presentation
08/02/12
Vanda Pharmaceuticals Q2 2012 Earnings Call Transcript
07/13/12
JMP Securities Healthcare Conference Presentation
06/11/12
Seventy Percent of Totally Blind People with Sleep Complaints Are Not Entrained to the 24 Hour Clock
06/11/12
Pleiomorphic Expression of N24HSWD in the Totally Blind
06/11/12
Significant Sleep Impairment in Totally Blind Individuals with N24HSWD
06/11/12
Timing and Duration of Nap Episodes are Coincident with Melatonin Acrophase
06/11/12
A National Registry of Totally Blind Individuals with Sleep-Wake Complaints
06/04/12
Jefferies Global Healthcare Conference Presentation
05/08/12
Vanda Pharmaceuticals Q1 2012 Earnings Call Transcript
02/27/12
VNDA - Q1 2012 Investor Conferences
02/14/12
Vanda Pharmaceuticals Q4 2011 Earnings Call Transcript
11/04/11
Vanda Pharmaceuticals Q3 2011 Earnings Call Transcript
09/20/11
UBS Global Life Sciences Conference Presentation
09/08/11
Stifel, Nicolaus & Company Inc. Healthcare Conference Presentation
08/04/11
Vanda Pharmaceuticals Q2 2011 Earnings Call Transcript
06/09/11
Jefferies & Co. Global Healthcare Conference Presentation
05/05/11
Vanda Pharmaceuticals Q1 2011 Earnings Call Transcript
02/10/11
Vanda Pharmaceuticals Q4 2010 Earnings Call Transcript
11/03/10
Vanda Pharmaceuticals Q3 2010 Earnings Call Transcript
08/05/10
Vanda Pharmaceuticals Q2 2010 Earnings Call Transcript
05/04/10
Vanda Pharmaceuticals Q1 2010 Earnings Call Transcript
03/09/10
Vanda Pharmaceuticals Inc. - Cowen Healthcare Conference March 9, 2010
02/16/10
Vanda Pharmaceuticals Q4 2009 Earnings Call Transcript
11/02/09
Vanda Pharmaceuticals Q3 2009 Earnings Call Transcript
08/10/09
Vanda Pharmaceuticals Q2 2009 Earnings Call Transcript
Get help downloading or viewing the above file types
IR Home
Stock Information
Press Releases
SEC Filings
Analyst Coverage
Presentations
Corporate Governance
Information Request
E-mail Alerts
Print Page
E-mail Page
